Methylene blue for burn-induced vasoplegia: case report and review of literature

We report the use of a single dose of methylene blue in a patient with burn-induced vasoplegia refractory to fluids, vasopressors, and steroids. Administration of methylene blue allowed for cessation of epinephrine infusion within 2 hours of administration, and reduction in excessive fluid resuscita...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of burn care & research 2015-03, Vol.36 (2), p.e107-e111
Hauptverfasser: Church, Joseph T, Posluszny, Joseph A, Hemmila, Mark, To, Kathleen B, Cherry-Bukowiec, Jill R, Waljee, Jennifer
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e111
container_issue 2
container_start_page e107
container_title Journal of burn care & research
container_volume 36
creator Church, Joseph T
Posluszny, Joseph A
Hemmila, Mark
To, Kathleen B
Cherry-Bukowiec, Jill R
Waljee, Jennifer
description We report the use of a single dose of methylene blue in a patient with burn-induced vasoplegia refractory to fluids, vasopressors, and steroids. Administration of methylene blue allowed for cessation of epinephrine infusion within 2 hours of administration, and reduction in excessive fluid resuscitation. The patient's clinical course continued for 2 months and was complicated by severe acute respiratory distress syndrome, pneumonia, septic shock, poor skin graft adherence, renal failure requiring continuous renal replacement therapy, cutaneous mucormycosis, and ultimately, withdrawal of care and death. Despite the eventual outcome, this is the longest reported survival following methylene blue administration for vasoplegia secondary to burn injury.
doi_str_mv 10.1097/BCR.0000000000000134
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1657317617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1657317617</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-c50103d38d7252ed564ea51a753c9e1ba68814aed05646061382f087c78892ae3</originalsourceid><addsrcrecordid>eNpdkN1LwzAUxYMobk7_A5E8-tKZNM1HfdPhF0wUUfCtpMmtVrK2Js1k_72VzSHel3vgnnMP_BA6pmRKSS7PLmdPU_J3KMt20JhynickU2p3q-XrCB2E8EFIlhHJ99Eo5UJJJugYPd5D_75y0AAuXQRctR6X0TdJ3dhowOKlDm3n4K3W59joANhD1_oe68YOclnDF24r7OoevO6jh0O0V2kX4GizJ-jl-up5dpvMH27uZhfzxAzlfWI4oYRZpqxMeQqWiww0p1pyZnKgpRZK0UyDJcNFEEGZSiuipJFK5akGNkGn67-dbz8jhL5Y1MGAc7qBNoaCCi4ZlYLKwZqtrca3IXiois7XC-1XBSXFD8tiYFn8ZznETjYNsVyA3YZ-4bFv88ZuOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1657317617</pqid></control><display><type>article</type><title>Methylene blue for burn-induced vasoplegia: case report and review of literature</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Church, Joseph T ; Posluszny, Joseph A ; Hemmila, Mark ; To, Kathleen B ; Cherry-Bukowiec, Jill R ; Waljee, Jennifer</creator><creatorcontrib>Church, Joseph T ; Posluszny, Joseph A ; Hemmila, Mark ; To, Kathleen B ; Cherry-Bukowiec, Jill R ; Waljee, Jennifer</creatorcontrib><description>We report the use of a single dose of methylene blue in a patient with burn-induced vasoplegia refractory to fluids, vasopressors, and steroids. Administration of methylene blue allowed for cessation of epinephrine infusion within 2 hours of administration, and reduction in excessive fluid resuscitation. The patient's clinical course continued for 2 months and was complicated by severe acute respiratory distress syndrome, pneumonia, septic shock, poor skin graft adherence, renal failure requiring continuous renal replacement therapy, cutaneous mucormycosis, and ultimately, withdrawal of care and death. Despite the eventual outcome, this is the longest reported survival following methylene blue administration for vasoplegia secondary to burn injury.</description><identifier>ISSN: 1559-047X</identifier><identifier>EISSN: 1559-0488</identifier><identifier>DOI: 10.1097/BCR.0000000000000134</identifier><identifier>PMID: 25687361</identifier><language>eng</language><publisher>England</publisher><subject>Burns - complications ; Burns - drug therapy ; Enzyme Inhibitors - therapeutic use ; Evidence-Based Medicine ; Humans ; Male ; Methylene Blue - therapeutic use ; Middle Aged ; Treatment Failure ; Vasoplegia - drug therapy ; Vasoplegia - etiology</subject><ispartof>Journal of burn care &amp; research, 2015-03, Vol.36 (2), p.e107-e111</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-c50103d38d7252ed564ea51a753c9e1ba68814aed05646061382f087c78892ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25687361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Church, Joseph T</creatorcontrib><creatorcontrib>Posluszny, Joseph A</creatorcontrib><creatorcontrib>Hemmila, Mark</creatorcontrib><creatorcontrib>To, Kathleen B</creatorcontrib><creatorcontrib>Cherry-Bukowiec, Jill R</creatorcontrib><creatorcontrib>Waljee, Jennifer</creatorcontrib><title>Methylene blue for burn-induced vasoplegia: case report and review of literature</title><title>Journal of burn care &amp; research</title><addtitle>J Burn Care Res</addtitle><description>We report the use of a single dose of methylene blue in a patient with burn-induced vasoplegia refractory to fluids, vasopressors, and steroids. Administration of methylene blue allowed for cessation of epinephrine infusion within 2 hours of administration, and reduction in excessive fluid resuscitation. The patient's clinical course continued for 2 months and was complicated by severe acute respiratory distress syndrome, pneumonia, septic shock, poor skin graft adherence, renal failure requiring continuous renal replacement therapy, cutaneous mucormycosis, and ultimately, withdrawal of care and death. Despite the eventual outcome, this is the longest reported survival following methylene blue administration for vasoplegia secondary to burn injury.</description><subject>Burns - complications</subject><subject>Burns - drug therapy</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Evidence-Based Medicine</subject><subject>Humans</subject><subject>Male</subject><subject>Methylene Blue - therapeutic use</subject><subject>Middle Aged</subject><subject>Treatment Failure</subject><subject>Vasoplegia - drug therapy</subject><subject>Vasoplegia - etiology</subject><issn>1559-047X</issn><issn>1559-0488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkN1LwzAUxYMobk7_A5E8-tKZNM1HfdPhF0wUUfCtpMmtVrK2Js1k_72VzSHel3vgnnMP_BA6pmRKSS7PLmdPU_J3KMt20JhynickU2p3q-XrCB2E8EFIlhHJ99Eo5UJJJugYPd5D_75y0AAuXQRctR6X0TdJ3dhowOKlDm3n4K3W59joANhD1_oe68YOclnDF24r7OoevO6jh0O0V2kX4GizJ-jl-up5dpvMH27uZhfzxAzlfWI4oYRZpqxMeQqWiww0p1pyZnKgpRZK0UyDJcNFEEGZSiuipJFK5akGNkGn67-dbz8jhL5Y1MGAc7qBNoaCCi4ZlYLKwZqtrca3IXiois7XC-1XBSXFD8tiYFn8ZznETjYNsVyA3YZ-4bFv88ZuOA</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Church, Joseph T</creator><creator>Posluszny, Joseph A</creator><creator>Hemmila, Mark</creator><creator>To, Kathleen B</creator><creator>Cherry-Bukowiec, Jill R</creator><creator>Waljee, Jennifer</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150301</creationdate><title>Methylene blue for burn-induced vasoplegia: case report and review of literature</title><author>Church, Joseph T ; Posluszny, Joseph A ; Hemmila, Mark ; To, Kathleen B ; Cherry-Bukowiec, Jill R ; Waljee, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-c50103d38d7252ed564ea51a753c9e1ba68814aed05646061382f087c78892ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Burns - complications</topic><topic>Burns - drug therapy</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Evidence-Based Medicine</topic><topic>Humans</topic><topic>Male</topic><topic>Methylene Blue - therapeutic use</topic><topic>Middle Aged</topic><topic>Treatment Failure</topic><topic>Vasoplegia - drug therapy</topic><topic>Vasoplegia - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Church, Joseph T</creatorcontrib><creatorcontrib>Posluszny, Joseph A</creatorcontrib><creatorcontrib>Hemmila, Mark</creatorcontrib><creatorcontrib>To, Kathleen B</creatorcontrib><creatorcontrib>Cherry-Bukowiec, Jill R</creatorcontrib><creatorcontrib>Waljee, Jennifer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of burn care &amp; research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Church, Joseph T</au><au>Posluszny, Joseph A</au><au>Hemmila, Mark</au><au>To, Kathleen B</au><au>Cherry-Bukowiec, Jill R</au><au>Waljee, Jennifer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methylene blue for burn-induced vasoplegia: case report and review of literature</atitle><jtitle>Journal of burn care &amp; research</jtitle><addtitle>J Burn Care Res</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>36</volume><issue>2</issue><spage>e107</spage><epage>e111</epage><pages>e107-e111</pages><issn>1559-047X</issn><eissn>1559-0488</eissn><abstract>We report the use of a single dose of methylene blue in a patient with burn-induced vasoplegia refractory to fluids, vasopressors, and steroids. Administration of methylene blue allowed for cessation of epinephrine infusion within 2 hours of administration, and reduction in excessive fluid resuscitation. The patient's clinical course continued for 2 months and was complicated by severe acute respiratory distress syndrome, pneumonia, septic shock, poor skin graft adherence, renal failure requiring continuous renal replacement therapy, cutaneous mucormycosis, and ultimately, withdrawal of care and death. Despite the eventual outcome, this is the longest reported survival following methylene blue administration for vasoplegia secondary to burn injury.</abstract><cop>England</cop><pmid>25687361</pmid><doi>10.1097/BCR.0000000000000134</doi></addata></record>
fulltext fulltext
identifier ISSN: 1559-047X
ispartof Journal of burn care & research, 2015-03, Vol.36 (2), p.e107-e111
issn 1559-047X
1559-0488
language eng
recordid cdi_proquest_miscellaneous_1657317617
source MEDLINE; Journals@Ovid Complete; Oxford University Press Journals All Titles (1996-Current)
subjects Burns - complications
Burns - drug therapy
Enzyme Inhibitors - therapeutic use
Evidence-Based Medicine
Humans
Male
Methylene Blue - therapeutic use
Middle Aged
Treatment Failure
Vasoplegia - drug therapy
Vasoplegia - etiology
title Methylene blue for burn-induced vasoplegia: case report and review of literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A10%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methylene%20blue%20for%20burn-induced%20vasoplegia:%20case%20report%20and%20review%20of%20literature&rft.jtitle=Journal%20of%20burn%20care%20&%20research&rft.au=Church,%20Joseph%20T&rft.date=2015-03-01&rft.volume=36&rft.issue=2&rft.spage=e107&rft.epage=e111&rft.pages=e107-e111&rft.issn=1559-047X&rft.eissn=1559-0488&rft_id=info:doi/10.1097/BCR.0000000000000134&rft_dat=%3Cproquest_cross%3E1657317617%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1657317617&rft_id=info:pmid/25687361&rfr_iscdi=true